Latest Cancer immunotherapy Stories
Cancer vaccines prime the immune system to attack cancer cells, decreasing tumor progression.
Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.
Published in the Journal for ImmunoTherapy of Cancer, review offers recommendations for manufacturing, pre-clinical studies, and clinical trial designs of cancer immunotherapies Milwaukee,
- A serpent whose bite was fabled to produce intense thirst.